Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Evolocumab |
Trade Name | |
Synonyms | AMG 145|AMG-145|AMG145|Repatha |
Drug Descriptions |
Evolocumab is a monoclonal antibody that targets PCSK9, potentially leading to decreased tumor growth (PMID: 33177715). |
DrugClasses | |
CAS Registry Number | 1256937-27-5 |
NCIT ID | C174672 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Evolocumab | Evolocumab | 0 | 0 |
Evolocumab + Ipilimumab + Nivolumab | Evolocumab Ipilimumab Nivolumab | 0 | 1 |
Evolocumab + Nivolumab | Evolocumab Nivolumab | 0 | 1 |